Sotera Health Company $SHC Stock Holdings Boosted by Sculptor Capital LP

Sculptor Capital LP boosted its stake in shares of Sotera Health Company (NASDAQ:SHC) by 57.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 21,000,000 shares of the company’s stock after purchasing an additional 7,658,200 shares during the period. Sotera Health makes up approximately 3.8% of Sculptor Capital LP’s portfolio, making the stock its 4th biggest holding. Sculptor Capital LP owned approximately 7.39% of Sotera Health worth $370,440,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the stock. CenterBook Partners LP raised its stake in shares of Sotera Health by 94.1% in the 4th quarter. CenterBook Partners LP now owns 151,529 shares of the company’s stock valued at $2,673,000 after acquiring an additional 73,473 shares during the period. Capricorn Fund Managers Ltd purchased a new position in shares of Sotera Health in the 4th quarter valued at $7,936,000. Nordea Investment Management AB purchased a new position in shares of Sotera Health in the 4th quarter valued at $1,908,000. Exchange Traded Concepts LLC purchased a new position in shares of Sotera Health in the 4th quarter valued at $7,739,000. Finally, Retirement Systems of Alabama raised its stake in shares of Sotera Health by 16.9% in the 4th quarter. Retirement Systems of Alabama now owns 248,899 shares of the company’s stock valued at $4,391,000 after acquiring an additional 35,974 shares during the period. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. Barclays cut their target price on shares of Sotera Health from $20.00 to $18.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. The Goldman Sachs Group assumed coverage on shares of Sotera Health in a research note on Friday, June 5th. They issued a “buy” rating and a $20.00 target price on the stock. Citigroup raised their target price on shares of Sotera Health from $21.00 to $23.00 and gave the company a “buy” rating in a research note on Tuesday, February 24th. Piper Sandler reissued an “overweight” rating and issued a $22.00 target price (down from $24.00) on shares of Sotera Health in a research note on Wednesday, May 6th. Finally, Wall Street Zen lowered shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. Eight equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $20.29.

Sotera Health Price Performance

SHC opened at $16.23 on Tuesday. The company has a fifty day simple moving average of $15.63 and a 200 day simple moving average of $16.37. The firm has a market cap of $4.63 billion, a price-to-earnings ratio of 39.59 and a beta of 1.79. Sotera Health Company has a twelve month low of $10.80 and a twelve month high of $19.85. The company has a current ratio of 2.82, a quick ratio of 2.54 and a debt-to-equity ratio of 3.56.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. The business had revenue of $280.05 million during the quarter, compared to analyst estimates of $270.78 million. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The business’s revenue was up 10.0% on a year-over-year basis. During the same period last year, the business earned $0.14 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. Equities research analysts expect that Sotera Health Company will post 0.86 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the firm’s stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total transaction of $193,194,516.17. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 15.36% of the company’s stock.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.